Procter & Gamble (NYSE:PG) Issues FY 2027 Earnings Guidance

Procter & Gamble (NYSE:PG) updated its FY 2027 earnings guidance on Friday. The company provided earnings per share guidance of 6.890-7.110 for the period, compared to the consensus estimate of 6.980. The company issued revenue guidance of $86.0 billion-$87.7 billion, compared to the consensus revenue estimate of $88.8 billion.

Wall Street Analysts Forecast Growth

PG has been the subject of several recent analyst reports. Wells Fargo & Company upped their target price on shares of Procter & Gamble from $164.00 to $180.00 and gave the company an “overweight” rating in a research note on Friday. Argus cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Friday, August 7th. BMO Capital Markets boosted their price target on shares of Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a report on Monday, June 29th. Citigroup upped their price objective on shares of Procter & Gamble from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Friday, October 9th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Procter & Gamble in a research note on Friday. Fourteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $167.00.

Procter & Gamble Stock Down 2.7%

NYSE PG traded down $4.44 during trading hours on Friday, reaching $161.15. 3,335,082 shares of the company’s stock were exchanged, compared to its average volume of 9,732,150. The company’s 50-day moving average is $148.08 and its two-hundred day moving average is $146.99. Procter & Gamble has a one year low of $137.62 and a one year high of $167.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. The company has a market capitalization of $374.30 billion, a price-to-earnings ratio of 24.33, a price-to-earnings-growth ratio of 3.90 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. During the same quarter in the prior year, the firm earned $1.99 earnings per share. The firm’s revenue was up 4.0% compared to the same quarter last year. On average, analysts forecast that Procter & Gamble will post 6.98 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be issued a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is 65.71%.

Insider Activity at Procter & Gamble

In other news, CAO Matthew W. Janzaruk sold 359 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $145.24, for a total value of $52,141.16. Following the sale, the chief accounting officer directly owned 1,271 shares in the company, valued at $184,600.04. This trade represents a 22.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Andre Schulten sold 3,914 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the transaction, the chief financial officer owned 65,618 shares of the company’s stock, valued at $9,536,920.12. The trade was a 5.63% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 15,135 shares of company stock valued at $2,189,970 over the last ninety days. Company insiders own 0.23% of the company’s stock.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Sales and earnings exceeded expectations. Fiscal first-quarter EPS was $2.00 versus the $1.89 consensus, while revenue rose 4% year over year to $23.28 billion, ahead of estimates. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Underlying demand improved. Organic sales grew 4%, with volume contributing 2.4 percentage points. Strength in laundry, home-care products and favorable product mix helped offset pressure on consumers and supported operating leverage. Procter & Gamble: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Analyst sentiment and the sales outlook improved. TD Cowen raised its price target from $150 to $166 while maintaining a Hold rating. P&G also lifted its fiscal 2027 all-in sales-growth outlook, partly reflecting the Thorne acquisition.
• Neutral Sentiment: Management remains focused on resilience and productivity. The company said consumer demand remains solid and expects productivity savings and mix benefits to aid profitability, but the full-year outlook leaves limited room for further upside. Procter & Gamble: Improving Operating Leverage
• Negative Sentiment: Commodity, energy and transportation costs are rising. P&G warned that higher input costs could create an approximately $1.4 billion annual headwind, pressuring margins and potentially offsetting sales gains. P&G flags bigger hit to annual profit
• Negative Sentiment: Guidance creates uncertainty. Fiscal 2027 revenue guidance of $86.0 billion-$87.7 billion is below the $88.8 billion consensus, while margins remain under pressure. After the recent surge toward a 52-week high, profit-taking and concerns about valuation may be weighing on PG.

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.